Trends in Healthcare Resource Use Preceding Diagnosis of Alzheimer's Disease Dementia.

Ibrahim M Abbass, Dae Choi, Christopher Wallick, Sheila Seleri Assunção
{"title":"Trends in Healthcare Resource Use Preceding Diagnosis of Alzheimer's Disease Dementia.","authors":"Ibrahim M Abbass,&nbsp;Dae Choi,&nbsp;Christopher Wallick,&nbsp;Sheila Seleri Assunção","doi":"10.1155/2023/8154701","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>An Alzheimer's disease (AD) dementia diagnosis is often preceded by an extended period of cognitive decline. Few studies have examined healthcare resource use (HRU) during an extended period before AD dementia diagnosis.</p><p><strong>Methods: </strong>In a historical claims-based cohort study, propensity score-matched cohorts of patients with and without AD dementia were observed for a 5-year prediagnosis period and a 1-year postdiagnosis period. Demographics, clinical characteristics, and HRU were compared between groups.</p><p><strong>Results: </strong>Individuals in the AD dementia group displayed a greater level of medical complexity in the year before diagnosis of AD dementia relative to those in the matched cohort. Both all-cause and AD dementia complication-related HRU increased gradually, with a marked spike at the time of initial AD dementia diagnosis. <i>Discussion</i>. Further research into the natural history of patients with AD dementia is necessary to improve identification of early AD and to better understand its broader impact.</p>","PeriodicalId":13802,"journal":{"name":"International Journal of Alzheimer's Disease","volume":"2023 ","pages":"8154701"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840544/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Alzheimer's Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2023/8154701","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Neuroscience","Score":null,"Total":0}
引用次数: 2

Abstract

Introduction: An Alzheimer's disease (AD) dementia diagnosis is often preceded by an extended period of cognitive decline. Few studies have examined healthcare resource use (HRU) during an extended period before AD dementia diagnosis.

Methods: In a historical claims-based cohort study, propensity score-matched cohorts of patients with and without AD dementia were observed for a 5-year prediagnosis period and a 1-year postdiagnosis period. Demographics, clinical characteristics, and HRU were compared between groups.

Results: Individuals in the AD dementia group displayed a greater level of medical complexity in the year before diagnosis of AD dementia relative to those in the matched cohort. Both all-cause and AD dementia complication-related HRU increased gradually, with a marked spike at the time of initial AD dementia diagnosis. Discussion. Further research into the natural history of patients with AD dementia is necessary to improve identification of early AD and to better understand its broader impact.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿尔茨海默病痴呆诊断前医疗资源使用趋势
简介:阿尔茨海默病(AD)痴呆症的诊断通常是在认知能力下降的延长期之前。很少有研究在AD痴呆诊断前的较长时间内检查医疗资源使用(HRU)。方法:在一项基于历史索赔的队列研究中,在诊断前5年和诊断后1年观察AD痴呆患者和非AD痴呆患者的倾向评分匹配队列。比较两组人口统计学、临床特征和HRU。结果:相对于匹配的队列,AD痴呆组的个体在AD痴呆诊断前一年表现出更高的医疗复杂性。全因和AD痴呆并发症相关HRU均逐渐升高,在AD痴呆初始诊断时出现明显的峰值。讨论。进一步研究阿尔茨海默病痴呆患者的自然史对于提高早期阿尔茨海默病的识别并更好地了解其广泛影响是必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Journal of Alzheimer's Disease
International Journal of Alzheimer's Disease Neuroscience-Behavioral Neuroscience
CiteScore
10.10
自引率
0.00%
发文量
3
审稿时长
11 weeks
期刊最新文献
Inflammatory Manifestations Associated With Gut Dysbiosis in Alzheimer's Disease. Advancements and Challenges in Antiamyloid Therapy for Alzheimer's Disease: A Comprehensive Review. Novel Biomarkers for Alzheimer’s Disease: Plasma Neurofilament Light and Cerebrospinal Fluid In Silico Investigation of Novel Compounds as Inhibitors of Acetylcholinesterase Enzyme for the Treatment of Alzheimer's Diseases In Silico Investigation of Novel Compounds as Inhibitors of Acetylcholinesterase Enzyme for the Treatment of Alzheimer's Diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1